Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure
In this study, group de Windt demonstrated that miR-148a expression changes dynamically in distinct subtypes of heart failure: while it is elevated in concentric hypertrophy, it decreased in dilated cardiomyopathy.